Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes
- PMID: 6604274
- PMCID: PMC384306
- DOI: 10.1073/pnas.80.18.5602
Flat revertants isolated from Kirsten sarcoma virus-transformed cells are resistant to the action of specific oncogenes
Abstract
Two flat revertants have been isolated from mutagen-treated populations of Kirsten murine sarcoma virus (Ki-MuSV)-transformed NIH/3T3 cells. These revertants, which appear to be cellular variants resistant to transformation by the Ki-MuSV oncogene v-Ki-ras, contain Ki-MuSV-specific DNA, elevated levels of the v-Ki-ras gene product p21, and rescuable transforming virus. Cell hybridization studies indicated that the revertant phenotype is dominant in hybrids between revertant cells and cells transformed by Ki-MuSV or the closely related Harvey MuSV and BALB MuSV. Analysis of hybrid cells resulting from the fusion of these revertants to cell lines transformed by other retroviruses showed that the action of certain oncogenes structurally unrelated to v-Ki-ras also could be suppressed. Thus, there appear to be functional relationships and diversities among transforming genes (oncogenes) not readily apparent from their structural characteristics.
Similar articles
-
Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.J Cell Physiol. 1984 Oct;121(1):22-30. doi: 10.1002/jcp.1041210105. J Cell Physiol. 1984. PMID: 6090475
-
Clonal dominance of select subsets of viral Kirsten ras(+)-transformed 3T3 cells during tumor progression.Int J Cancer. 1991 Apr 22;48(1):148-59. doi: 10.1002/ijc.2910480126. Int J Cancer. 1991. PMID: 2019453
-
Expression of Kirsten murine sarcoma virus in transformed nonproducer and revertant NIH/3T3 cells: evidence for cell-mediated resistance to a viral oncogene in phenotypic reversion.J Virol. 1984 May;50(2):439-44. doi: 10.1128/JVI.50.2.439-444.1984. J Virol. 1984. PMID: 6323744 Free PMC article.
-
Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus.Virology. 1979 Jul 15;96(1):64-79. doi: 10.1016/0042-6822(79)90173-9. Virology. 1979. PMID: 223311
-
Adhesion of Kirsten-ras+ tumor-progressing and Kirsten-ras- revertant 3T3 cells on fibronectin proteolytic fragments.Cancer Res. 1990 Jul 15;50(14):4388-400. Cancer Res. 1990. PMID: 2163749
Cited by
-
Suppression of tropomyosin synthesis, a common biochemical feature of oncogenesis by structurally diverse retroviral oncogenes.Mol Cell Biol. 1985 May;5(5):972-83. doi: 10.1128/mcb.5.5.972-983.1985. Mol Cell Biol. 1985. PMID: 4000123 Free PMC article.
-
Interferon-induced revertants of ras-transformed cells: resistance to transformation by specific oncogenes and retransformation by 5-azacytidine.Mol Cell Biol. 1987 Jun;7(6):2196-200. doi: 10.1128/mcb.7.6.2196-2200.1987. Mol Cell Biol. 1987. PMID: 2439904 Free PMC article.
-
Suppression of tumorigenicity with continued expression of the c-Ha-ras oncogene in EJ bladder carcinoma-human fibroblast hybrid cells.Proc Natl Acad Sci U S A. 1986 Jul;83(14):5209-13. doi: 10.1073/pnas.83.14.5209. Proc Natl Acad Sci U S A. 1986. PMID: 3523486 Free PMC article.
-
Activated PAK4 regulates cell adhesion and anchorage-independent growth.Mol Cell Biol. 2001 May;21(10):3523-33. doi: 10.1128/MCB.21.10.3523-3533.2001. Mol Cell Biol. 2001. PMID: 11313478 Free PMC article.
-
A model for tumor suppression using H-1 parvovirus.Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8702-6. doi: 10.1073/pnas.90.18.8702. Proc Natl Acad Sci U S A. 1993. PMID: 8378352 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources